Education
About Us
Working with TipRanks
Follow Us
Phreesia (PHR)
NYSE:PHR
Earnings Data
Report Date
Sep 03, 2025TBA Not Confirmed
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.07Last Year’s EPS
-0.31Same Quarter Last Year
Strong Buy
Based on 12 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 28, 2025
|% Change Since: 6.69%
|Next Earnings Date:Sep 03, 2025
Earnings Call Sentiment|Positive
Phreesia's earnings call shows a positive overall performance with strong revenue growth, improved EBITDA, and positive cash flows. However, there are some uncertainties regarding network solutions pacing and potential risks from legislative changes affecting pharmaceutical advertising revenue.Company Guidance
During the Phreesia First Quarter Fiscal 2026 Earnings Call, CFO Balaji Gandhi provided detailed guidance and financial performance metrics. The company reported a revenue of $115.9 million, marking a 15% year-over-year increase, and an adjusted EBITDA of $20.8 million, representing a 16.7% growth with an 18% EBITDA margin. The average healthcare services clients reached 4,411, increasing by 70 from the prior quarter and 346 from the previous year, while revenue per average healthcare services clients grew by 6% year-over-year to $26,283. The company ended the quarter with $90.9 million in cash and cash equivalents, with a positive free cash flow of $7.5 million, up $13.7 million year-over-year. Phreesia maintained its revenue outlook for fiscal year 2026 between $472 million to $482 million and revised its adjusted EBITDA range to $85 million to $90 million, reflecting a $4.5 million increase at the midpoint from previous guidance.Strong Revenue Growth
Revenue was $115.9 million, an increase of 15% year-over-year.
Increased EBITDA
Adjusted EBITDA was $20.8 million, an increase of 16.7% year-over-year with an adjusted EBITDA margin of 18%.
Positive Cash Flow
Operating cash flow remained positive at $14.9 million, up $15.6 million year-over-year. Free cash flow also stayed positive at $7.5 million, up $13.7 million year-over-year.
Updated EBITDA Outlook
The company updated its adjusted EBITDA outlook for fiscal year 2026 to a range of $85 million to $90 million, an increase of $4.5 million from the prior guidance midpoint.
Growth in Healthcare Services Clients
The company ended the quarter with average healthcare services clients of 4,411, an increase of 70 from the prior quarter and 346 from the prior year.
PHR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PHR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 28, 2025 | $24.95 | $23.30 | -6.61% |
Mar 12, 2025 | $23.80 | $25.45 | +6.93% |
Dec 09, 2024 | $21.63 | $24.14 | +11.60% |
Sep 04, 2024 | $24.17 | $25.69 | +6.29% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Phreesia (PHR) report earnings?
Phreesia (PHR) is schdueled to report earning on Sep 03, 2025, TBA Not Confirmed.
What is Phreesia (PHR) earnings time?
Phreesia (PHR) earnings time is at Sep 03, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PHR EPS forecast?
PHR EPS forecast for the fiscal quarter 2026 (Q2) is -0.07.